Hematopoietic stem cell transplantation for cytidine triphosphate synthase 1 (CTPS1) deficiency
Bone Marrow Transplant
.
2019 Jan;54(1):130-133.
doi: 10.1038/s41409-018-0246-x.
Epub 2018 Jun 8.
Authors
Zohreh Nademi
1
2
,
Robert F Wynn
3
,
Mary Slatter
4
5
,
Stephen M Hughes
3
,
Denise Bonney
3
,
Waseem Qasim
6
,
Sylvain Latour
7
,
Johannes Trück
8
,
Smita Patel
9
,
Mario Abinun
4
5
,
Terry Flood
4
,
Sophie Hambleton
4
5
,
Andrew J Cant
4
5
,
Andrew R Gennery
4
5
,
Peter D Arkwright
3
Affiliations
1
Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
[email protected]
.
2
Primary Immunodeficiency Group, Institute of Cellular Medicine, Newcastle upon Tyne University, Newcastle upon Tyne, UK.
[email protected]
.
3
University of Manchester, Royal Manchester Children's Hospital, Manchester, UK.
4
Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
5
Primary Immunodeficiency Group, Institute of Cellular Medicine, Newcastle upon Tyne University, Newcastle upon Tyne, UK.
6
Department of Pediatric Immunology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
7
Laboratory of Lymphocyte Activation and susceptibility to EBV infection, Inserm UMR 1163, Hôspital Necker-Enfants, Paris, France.
8
Division of Immunology and the Children's Research Center, University Children's Hospital, University of Zurich, Zurich, Switzerland.
9
Oxford NIHR Biomedical Research Centre, Oxford, UK.
PMID:
29884857
DOI:
10.1038/s41409-018-0246-x
No abstract available
Publication types
Letter
MeSH terms
Allografts
Biosimilar Pharmaceuticals
Carbon-Nitrogen Ligases / deficiency*
Female
Hematopoietic Stem Cell Transplantation*
Humans
Male
Substances
Biosimilar Pharmaceuticals
Carbon-Nitrogen Ligases
CTP synthetase
Grants and funding
RP-2014-05-007/DH_/Department of Health/United Kingdom